IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Octagon Capital Advisors LP

Q3 2021 Holdings

Filed 2021-11-15 | 30 holdings | $148.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$41.1M761,39827.7%
Arcus Biosciences Inc(RCUS)COM03969F109$33.8M970,16422.8%
Bridgebio Pharma Inc(BBIO)COM10806X102$26.7M569,41418.0%
Century Therapeutics Inc(IPSC)COM15673T100$15.2M602,62310.2%
Arvinas Inc(ARVN)COM04335A105$13.8M168,5009.3%
Cytek Biosciences Inc(CTKB)COM23285D109$10.7M500,0007.2%
Cardiff Oncology Inc(CRDF)COM14147L108$6.5M982,7534.4%
I MAB(NBP)SPONSORED ADS44975P103$55.4K764,4610.0%
Apellis Pharmaceuticals Inc(APLS)COM03753U106$52.6K1,595,9110.0%
4D Molecular Therapeutics in(FDMT)COM35104E100$22.4K831,2670.0%
Gossamer BIO Inc(GOSS)COM38341P102$19.0K1,513,1380.0%
Curis Inc(CRISEUR)COM NEW231269200$18.0K2,294,7210.0%
Vera Therapeutics Inc(VERA)CL A92337R101$12.1K696,1260.0%
Avidity Biosciences Inc(RNA)COM05370A108$11.0K446,6410.0%
Dyne Therapeutics Inc(DYN)COM26818M108$9.5K583,6490.0%
Connect Biopharma Hldgs LTDADS207523101$7.8K326,1430.0%
Stoke Therapeutics Inc(STOK)COM86150R107$7.6K296,8220.0%
Omega Therapeutics IncCOMMON STOCK68217N105$7.0K370,2790.0%
Prometheus Biosciences IncCOM74349U108$4.7K200,0000.0%
Ambrx Biopharma IncSPONSORED ADS02290A102$4.7K350,0000.0%
Iveric BIO Inc(OPHTEUR)COM46583P102$4.5K277,0570.0%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$4.2K200,0000.0%
Helix Acquisition CorpCOM CL AG4444C102$3.9K400,0000.0%
Ikena Oncology IncCOM45175G108$3.5K275,0000.0%
Monte Rosa Therapeutics Inc(GLUE)COM61225M102$3.3K150,0000.0%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$3.0K100,1410.0%
Jiya Acquisition CorpCOM CL A47760M102$2.9K300,0000.0%
Edgewise Therapeutics Inc(EWTX)COM28036F105$83050,0000.0%
Design Therapeutics Inc(DSGN)COM25056L103$21914,9260.0%
Tenax Therapeutics IncCOM NEW88032L209$5430,6000.0%